KFG Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Buy
+633
New +$235K 0.03% 202
2026
Q1
Sell
-650
Closed -$228K 218
2025
Q4
$228K Sell
650
-88
-12% -$29.7K 0.03% 197
2025
Q3
$238K Sell
738
-131
-15% -$40.7K 0.03% 188
2025
Q2
$338K Sell
869
-93
-10% -$37.4K 0.05% 151
2025
Q1
$418K Sell
962
-10
-1% -$4.01K 0.08% 124
2024
Q4
$359K Sell
972
-30
-3% -$12.6K 0.07% 128
2024
Q3
$521K Sell
1,002
-30
-3% -$16K 0.11% 108
2024
Q2
$559K Buy
1,032
+70
+7% +$37K 0.22% 83
2024
Q1
$499K Sell
962
-40
-4% -$19.9K 0.21% 89
2023
Q4
$473K Hold
1,002
0.22% 78
2023
Q3
$436K Sell
1,002
-122
-11% -$55.3K 0.24% 76
2023
Q2
$499K Sell
1,124
-90
-7% -$41.5K 0.29% 62
2023
Q1
$602K Hold
1,214
0.42% 38
2022
Q4
$623K Buy
+1,214
New +$616K 0.64% 32

Other funds holding ELV

KFG Wealth Management's ELV Position: Q2 2026 in Review

KFG Wealth Management opened a new position in Elevance Health (ELV) in Q2 2026: 633 shares worth $245K. The stake represents 0.03% of the portfolio and ranks #202 among its holdings. This is a return to the name: KFG Wealth Management previously reported a position in ELV as recently as Q4 2025.

KFG Wealth Management first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $623K in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • KFG Wealth Management held 633 shares of Elevance Health worth $245K as of Q2 2026.
  • Elevance Health was a new KFG Wealth Management position in Q2 2026.
  • Elevance Health made up 0.03% of KFG Wealth Management's portfolio in Q2 2026, its #202 holding.
  • KFG Wealth Management first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • KFG Wealth Management's Elevance Health position peaked at $623K in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on KFG Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.